BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company, is focused on utilizing its innovative and proprietary patented drug delivery technologies to develop and commercialize new applications of proven therapeutics. Currently, the company is developing formulations of pharmaceuticals primarily targeted at treatment opportunities in areas such as pain and infections. For further information, visit the Company’s web site at www.biodeliverysciences.com.
- 17 years ago
QualityStocks
BioDelivery Sciences International, Inc. (NASDAQ: BDSI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – BluSky AI Inc. (OTC: BSAI) Launches SkyMod Series for Scalable, Rapid-Deploy AI Datacenters
BluSky AI (OTC: BSAI) announced the completion of its modular AI datacenter infrastructure, unveiling the…
-
Newton Golf Company Inc. (NASDAQ: NWTG) Unveils Lighter Shaft amid Women’s Golf Boom
Women make up roughly 28% of on-course golfers in the United States, a historic high.…
-
Soligenix Inc. (NASDAQ: SNGX) Makes Advancement in Proprietary Treatment for Behçet’s Disease
Behçet’s disease is more prevalent in countries along the Silk Road, including Türkiye, Iran and…